PNC Financial Services Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.3K | Sell |
11,117
-487
| -4% | -$1.33K | ﹤0.01% | 3367 |
|
|
2025
Q1 | $19.5K | Buy |
11,604
+1,573
| +16% | +$2.64K | ﹤0.01% | 3551 |
|
|
2024
Q4 | $16.4K | Buy |
10,031
+10,011
| +50,055% | +$16.3K | ﹤0.01% | 3622 |
|
|
2024
Q3 | $83 | Hold |
20
| – | – | ﹤0.01% | 4730 |
|
|
2024
Q2 | $109 | Buy |
20
+13
| +186% | +$71 | ﹤0.01% | 4713 |
|
|
2024
Q1 | $70 | Buy |
+7
| New | +$70 | ﹤0.01% | 4654 |
|
|
2023
Q3 | – | Sell |
-600
| Closed | -$3.58K | – | 4731 |
|
|
2023
Q2 | $3.58K | Hold |
600
| – | – | ﹤0.01% | 4204 |
|
|
2023
Q1 | $1.96K | Hold |
600
| – | – | ﹤0.01% | 4316 |
|
|
2022
Q4 | $2.37K | Hold |
600
| – | – | ﹤0.01% | 4206 |
|
|
2022
Q3 | $4K | Hold |
600
| – | – | ﹤0.01% | 4033 |
|
|
2022
Q2 | $4K | Hold |
600
| – | – | ﹤0.01% | 4065 |
|
|
2022
Q1 | $5K | Sell |
600
-45
| -7% | -$375 | ﹤0.01% | 4010 |
|
|
2021
Q4 | $10K | Hold |
645
| – | – | ﹤0.01% | 3794 |
|
|
2021
Q3 | $15K | Sell |
645
-555
| -46% | -$12.9K | ﹤0.01% | 3623 |
|
|
2021
Q2 | $24K | Buy |
1,200
+600
| +100% | +$12K | ﹤0.01% | 3398 |
|
|
2021
Q1 | $20K | Buy |
+600
| New | +$20K | ﹤0.01% | 3416 |
|